Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.
23RD November 2012 DAILY CHARTIST VIEW HIGHLIGHTS A Highlights Nifty was bullish on Thursday. Nifty Future up 18.35 at 5640.45 We recommended two calls. Auro Pharma buy call hit target and Century Textile was not executed. Investors’ kindly book profit in Auro Pharma and take positions in the following calls. Sell DLF below 196 for targets 193/189 Sell Century Textile futures below 375 for targets 371/365 Past Performance: Ambuja Cement sell call hit both targets. Auro Pharma sell call hit both targets on the same day of execution. Lupin almost hit 2 nd target. Bata India hit both targets Havells sell call hit both targets. R Power hit target same day of execution AP paper sell call hit both targets. DLF FUTURE - HEAD & SHOULDER SELL BELOW 196 FOR TARGETS 193/189 SL 199 BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235 Sell DLF below 193 DLF is making head and shoulder on hourly chart Currently trading at 201.50 Break will below 197 and we expect rally to continue till 189 Investors’ can sell below 196 for targets 193/189 Stop loss is recommended at 199 CENTURY TEXTILE FUTURE- DOUBLE TOP SELL BELOW 375 FOR TARGETS 371/365 SL 381 Sell Century Textile future below 375 Century textile is making Double top on Daily Chart Currently trading at 389.60 Break out will come below 375 and expect rally to continue till 360 This is a positional call and may take time in execution. Stop loss is recommended at 381 Disclaimer The information and view in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any other information provided by us to/with anyone which is related directly or indirectly with them. If found so, then Serious Legal Actions can be taken.
Pages to are hidden for
"DAILY SPECIAL REPORT BY EPIC RESEARCH- 23 NOVEMBER 2012"Please download to view full document